Login / Signup

Rituximab versus cyclophosphamide for remission induction in active, severe ANCA-associated vasculitis.

Siddharth JainGsrsnk NaiduAman Sharma
Published in: Arthritis & rheumatology (Hoboken, N.J.) (2021)
Keyphrases
  • diffuse large b cell lymphoma
  • low dose
  • high dose
  • early onset
  • disease activity
  • hodgkin lymphoma
  • ulcerative colitis
  • chronic lymphocytic leukemia